Research Awards
Department of Medicine faculty and fellows have been recently awarded a number of exciting research awards.
David Baker, MD, MPH, Chief of the Division of General Internal Medicine and Geriatrics, is the 2013 Alvan R. Feinstein Award recipient. The Feinstein Award is one of the American College of Physicians' most prestigious honors. It is presented biannually to a physician who has made a major contribution to the science of clinical epidemiology, Dr. Baker will receive the award at a convocation ceremony in April in San Francisco. This story was originally reported in the Feinberg School of Medicine's News Center. Click here to read the original text.
Jonathan Licht, MD, professor and chief of the Division of Hematology-Oncology, received a $6.25 million grant from the Leukemia & Lymphoma Society's Marshall A. Lichtman Specialized Center of Research (SCOR) initiative. With the grant, Dr. Licht and his team hope to discover how mutant epigenetic proteins cause blood cancers, develop animal models of these processes, solve the detailed atomic structure of the proteins, and begin to develop therapies to reverse the abnormalities. Read more about the grant.
Andrea Dunaif, MD, of the Division of Endocrinology, has been awarded a P50 Competing Continuation entitled, “Genes, Androgens and Intrauterine Environment in PCOS.” Read more about this study. Dr. Dunaif is the Charles F. Kettering Professor of Endocrinology and Metabolism and the Vice Chair for Research of the Department of Medicine.
Jeffrey Barsuk, MD, of the Division of Hospital Medicine, has been awarded an R18 from AHRQ entitled, “Use of Simulation-Based Mastery Learning for Thoracentesis to Improve Outcomes.”
Lisa Van Wagner, MD, a fellow in the Division of Gastroenterology and Hepatology, has recently been awarded a National Research Service Award (NRSA) for individual postdoctoral fellows (Parent F32) from the National Heart, Lung and Blood Institute (NHLBI) to in order investigate innovative risk assessment techniques to better discover and delineate the cardiovascular risks associated with end-stage liver disease and organ transplantation. She will be under the multidisciplinary mentorship of Dr. Michael Abecassis, Director of the Comprehensive Transplant Center; Dr. Anton Skaro, Chairman of the Risk Prediction and Economics Workgroup of the Northwestern University Transplant Outcomes Research collaborative (NUTORC); and Dr. Donald Lloyd-Jones of the Department of Preventative Medicine. Read more about this project.
